The Efficacy of Three Months-prednisolone Therapy for Chronic Eosinophilic Pneumonia

Hamamatsu University50 enrolled

Overview

A comparison of 3 months-prednisolone administration with 6 months-prednisolone therapy in the treatment of chronic eosinophilic pneumonia. Three months-prednisolone administration may be as effective as 6 months-therapy.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

NONE

Enrollment

Conditions

Eosinophilic Pneumonia Chronic Disease

Interventions

prednisolone 0.5 mg/kg/day for three monthsDRUG

period of treatment

prednisolone 0.5 mg/kg/day for six monthsDRUG

period of therapy

Eligibility

Sex: ALLMin age: 16 YearsMax age: 80 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Biopsy-proven chronic eosinophilic pneumonia Exclusion Criteria: * Patients who received oral glucocorticosteroid (more than 10 mg) * Immunosuppressive drug

Locations (1)

Hamamatsu University School of Medicine

Hamamatsu, Japan

Outcomes

Primary Outcomes

Efficacy of 3 versus 6 months-prednisolone therapy for chronic eosinophilic pneumonia

Time frame: Three years

Secondary Outcomes

Safety of 3 versus 6 months-prednisolone therapy for chronic eosinophilic pneumonia

Time frame: Three years

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.